healthcare professionals

Navamedic will be presenting its Q1 numbers on Tuesday, May 10 at 08:30 at Haakon VII Gate 2 in Oslo

Click here for webcast of presentation
CEO update

“We work systematically to strengthen our core business by delivering growth through the introduction of new products in existing markets and expanding products to new geographies. We have started and will continue the tedious process to increase company value by owning new products and brands. As a third step, we have been and will actively continue to source and evaluate M&A opportunities to deliver sustainable growth with the objective of building Navamedic to a leading Nordic pharmaceutical company with a footprint in North Europe and other selected countries,” says Kathrine Gamborg Andreassen, CEO of Navamedic ASA.

CEO update
Meet us at exhibitions and fairs
Text
Country
Date
Text
Country
Date
NCDV
Denmark
April 19-21
NCDV
Denmark
April 19-21
SSIS
Sweden
April 27-28
SSIS
Sweden
April 27-28
Apteekkaripäivät
Finland
May 5-6
Apteekkaripäivät
Finland
May 5-6
FSU
Norway
September 8-9
FSU
Norway
September 8-9